Steven Wayne Pedersen

Title: Innovations of Steven Wayne Pedersen

Introduction

Steven Wayne Pedersen is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work primarily focuses on compounds and formulations that address neurological and psychiatric disorders.

Latest Patents

Among his latest patents, one includes compounds of a formula entitled, trans-4-[[[5S)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid, as a free acid or a pharmaceutically acceptable salt thereof, hydrate, and hydrate in crystalline form. This patent also covers pharmaceutical formulations and methods of use. Another significant invention relates to synthetic excitatory amino acid prodrugs and processes for their preparation. This invention further includes methods of using and pharmaceutical compositions comprising the compounds for the treatment of neurological disorders and psychiatric disorders.

Career Highlights

Steven Wayne Pedersen is currently associated with Eli Lilly and Company, a leading pharmaceutical firm. His work at Eli Lilly has allowed him to contribute to innovative solutions in the medical field, particularly in drug development.

Collaborations

He has collaborated with notable coworkers such as David Scott Coffey and James Allen Monn, enhancing the impact of his inventions through teamwork and shared expertise.

Conclusion

Steven Wayne Pedersen's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of neurological and psychiatric disorders.